SCHEMBL29671254

SCHEMBL29671254

CN(C)S(=O)(=O)c1c(F)c(F)c(F)c(F)c1C(=O)Nc1ccccc1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GAA P10253 1/20 0.62
▸ MEN1 O00255 6/20 0.56
▸ KMT2A Q03164 6/20 0.56
▸ CYP3A4 P08684 1/20 0.49
▸ CYP2C9 P11712 1/20 0.49
▸ CYP2C19 P33261 1/20 0.49
▸ CA1 P00915 2/20 0.47
▸ CA2 P00918 2/20 0.47
▸ SMN1; SMN2 Q16637 4/20 0.46
▸ MAPK1 P28482 3/20 0.46
▸ ALDH1A1 P00352 1/20 0.46
▸ NPSR1 Q6W5P4 1/20 0.46
▸ TSHR P16473 2/20 0.46
▸ HTT P42858 4/20 0.44
▸ TP53 P04637 2/20 0.44
▸ MAPT P10636 2/20 0.44
▸ GLA P06280 1/20 0.44
▸ CRHBP P24387 1/20 0.44
▸ CRHR2 Q13324 1/20 0.44
▸ NPC1 O15118 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29671224 0.80 HSD11B1 (0.41) GAAMEN1KMT2ASMN1; SMN2ALDH1A1
SCHEMBL21551666 0.78 GAA (1.00) GAAMEN1KMT2ACA1CA2
SCHEMBL27020038 0.78 SMN1; SMN2 (0.55) GAAMEN1KMT2ACYP3A4CYP2C9
SCHEMBL29671263 0.77 SMN1; SMN2 (0.38) MEN1KMT2ACYP3A4CYP2C9CYP2C19
SCHEMBL2298723 0.77 GAA (0.96) GAAMEN1KMT2ACA1CA2
SCHEMBL27020189 0.75 HDAC6 (0.34) MEN1KMT2ACA1CA2SMN1; SMN2
SCHEMBL29899439 0.75 MAPT (0.55) KMT2ACYP2C9CYP2C19CA1CA2
SCHEMBL29181613 0.72 GAA (0.79) GAAMEN1KMT2ACA1CA2
SCHEMBL29671257 0.72 CA1 (0.50) KMT2ACA1CA2MAPK1ALDH1A1
SCHEMBL29671286 0.72 HDAC6 (0.34) CA1CA2HDAC3HDAC11HDAC8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12559454-B2 Benzenesulfonamide derivatives and uses thereof 2692372 ONTARIO, INC. (CA) 2026-02-24 — — US disclosed
US-20220281812-A1 BENZENESULFONAMIDE DERIVATIVES AND USES THEREOF 2692372 ONTARIO INC (CA) 2022-09-08 — — US disclosed
CN-114502533-A Benzenesulfonamide derivatives and use thereof 2692372安大略公司 2022-05-13 — — CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12559454-B2 Benzenesulfonamide derivatives and uses thereof NR2E1, NR2C2, NR3C1 GAA 4103/4885MEN1 4205/4885KMT2A 4678/4885
US-20220281812-A1 BENZENESULFONAMIDE DERIVATIVES AND USES THEREOF BCR, ARSA, VHL GAA 727/4885MEN1 3413/4885KMT2A 4188/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback